Affiliation:
1. Ege University, Faculty of Medicine, Department of Medical Biology, Izmir, Turkey
2. Ege University, Faculty of Science, Department of Biochemistry, Izmir, Turkey
Abstract
The safety and efficacy of each drug candidate, including nanomedicine
considered for pharmaceutical use, primarily must be determined in vitro. In this
context, the most widely used method is cytotoxicity tests, which include cell culture
studies. It examines the parameters of membrane integrity, metabolite incorporation,
structural alteration, survival and growth in tissue culture, enzyme assays, and the
capacity for transplantation within the scope of viability tests. Within the scope of cell
culture studies, tests related to apoptosis, which are effective in proper cell cycle,
immune system and embryonic development, are also included. Another way to detect
cell viability is to detect the biomolecules it expresses. Determination of protein
expression is one of the preferred methods in this sense. Within the scope of this
chapter, there is information about cell culture-based methods under these main
subjects, which are applied to nanomedicines.
Publisher
BENTHAM SCIENCE PUBLISHERS
Reference70 articles.
1. Li W.; Zhou J.; Study of the In Vitro cytotoxicity testing of medical devices (Review). Biomed Rep 2015,617-620
2. Reddy L. H.; Arias J. L.; Nicolas J.; Magnetic nanoparticles: Design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications. Chem Rev 2012,5818-5878
3. ve Q.He; J Shi.; Mesoporous silica nanoparticle based nano drug delivery systems: synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibility. Biochim Biophys Acta 2011,21(16),5845-5855
4. Kunzmann A.; Andersson B.; Thurnherr T.; Krug H.; Scheynius A.; Fadeel B.; Toxicology of engineered nanomaterials: Focus on biocompatibility, biodistribution and biodegradation. Biochim Biophys Acta 2011,1810(3),361-373
5. Stoddart M.J.; içinde Mammalian Cell Viability: Methods and Protocols, 2011,1-6